DMAB-anabaseine dihydrochloride

CAS No. 154149-38-9

DMAB-anabaseine dihydrochloride( N,N-dimethyl-4-[(E)-(6-pyridin-3-yl-3,4-dihydro-2H-pyridin-5-ylidene)methyl]aniline | dihydrochloride )

Catalog No. M27623 CAS No. 154149-38-9

DMAB-anabaseine dihydrochloride is an α7-containing neuronal nicotinic receptor partial agonist and an antagonist at α4β2 and other nicotinic receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 72 In Stock
5MG 107 In Stock
10MG 155 In Stock
25MG 261 In Stock
50MG 366 In Stock
100MG 535 In Stock
200MG 724 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DMAB-anabaseine dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    DMAB-anabaseine dihydrochloride is an α7-containing neuronal nicotinic receptor partial agonist and an antagonist at α4β2 and other nicotinic receptors.
  • Description
    DMAB-anabaseine dihydrochloride is an α7-containing neuronal nicotinic receptor partial agonist and an antagonist at α4β2 and other nicotinic receptors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    N,N-dimethyl-4-[(E)-(6-pyridin-3-yl-3,4-dihydro-2H-pyridin-5-ylidene)methyl]aniline | dihydrochloride
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    Human Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    154149-38-9
  • Formula Weight
    364.31
  • Molecular Formula
    C19H23Cl2N3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.Cl.CN(C)c1ccc(\C=C2/CCCN=C2c2cccnc2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.1. Nouioua S, et al. Creatine deficiency syndrome. A treatable myopathy due to arginine-glycine amidinotransferase (AGAT) deficiency. Neuromuscul Disord. 2013 Aug;23(8):670-4.
molnova catalog
related products
  • SCH 57790

    SCH 57790 is a novel and selective muscarinic M(2) receptor antagonist that releases acetylcholine and enhances cognition in experimental animals for the treatment of Alzheimer's disease.

  • SSR180711 hydrochlor...

    SSR180711 hydrochloride (SSR-180711A HCl) is a selective Alpha7 nicotinic acetylcholine partial agonist for the study of neurodegenerative and cognitive disorders.

  • VU0152099

    VU0152099 is a potent and selective M4 mAChR allosteric potentiator(EC50 = 380 ± 93 nM).